ONTOLOGY REPORT - ANNOTATIONS

Term:altered tumor susceptibility
go back to main search page
Accession:MP:0002166 term browser browse the term
Definition:greater than or less than the average number of tumors, usually a specific type, arising in a given organism when compared to controls
Synonyms:exact_synonym: altered tumor resistance;   tumorigenesis: altered tumor susceptibility/resistance
 xref: MGI:2173626

  • Rat
  • Mouse
  • Human
  • All
  • show annotations for term's descendants
  •     Sort by:
carcinoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S BDII TAS RGD:1004 RGD
S BDIX TAS RGD:1004 RGD
S BDV IED RGD:724787 RGD
S WF/CrCrli IED RGD:1625309 RGD
chronic myelocytic leukemia term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S BDIX TAS RGD:1004 RGD
decreased hepatoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Hcar1 Hepatocarcinoma resistance QTL 1 GBrowse link IED 10 6,172,805 36,254,741 RGD:619598 RGD
Q Hcar10 Hepatocarcinoma resistance QTL 10 GBrowse link IED 8 43,313,902 87,122,960 RGD:629566 RGD
Q Hcar11 Hepatocarcinoma resistance QTL 11 GBrowse link IED 6 41,300,997 115,238,799 RGD:629566 RGD
Q Hcar12 Hepatocarcinoma resistance QTL 12 GBrowse link IED 3 25,775,548 118,863,223 RGD:629566 RGD
Q Hcar13 Hepatocarcinoma resistance QTL 13 GBrowse link IED 4 1 29,414,068 RGD:737884 RGD
Q Hcar14 Hepatocarcinoma resistance QTL 14 GBrowse link IED 18 53,847,682 86,863,412 RGD:737884 RGD
Q Hcar15 Hepatocarcinoma resistance QTL 15 GBrowse link IED 1 156,124,624 247,322,277 RGD:1358145 RGD
Q Hcar2 Hepatocarcinoma resistance QTL 2 GBrowse link IED 4 78,035,196 135,074,488 RGD:619598 RGD
Q Hcar3 Hepatocarcinoma resistance QTL 3 GBrowse link IED 8 57,308,572 103,684,785 RGD:619598 RGD
Q Hcar4 Hepatocarcinoma resistance QTL 4 GBrowse link IED 1 198,396,580 220,639,653 RGD:619609 RGD
Q Hcar5 Hepatocarcinoma resistance QTL 5 GBrowse link IED 1 220,639,539 232,579,992 RGD:619609 RGD
Q Hcar6 Hepatocarcinoma resistance QTL 6 GBrowse link IED 1 224,822,211 267,910,886 RGD:619609 RGD
Q Hcar7 Hepatocarcinoma resistance QTL 7 GBrowse link IED 4 58,550,170 93,498,821 RGD:619609 RGD
Q Hcar8 Hepatocarcinoma resistance QTL 8 IED RGD:619609 RGD
Q Hcar9 Hepatocarcinoma resistance QTL 9 GBrowse link IED 4 106,554,769 171,204,531 RGD:629566 RGD
decreased incidence of chemically-induced tumors term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Mamtr6 Mammary tumor resistance QTL 6 GBrowse link Induced TAS 18 19,892,650 86,863,412 RGD:2302423 RGD
Q Mamtr7 Mammary tumor resistance QTL 7 GBrowse link Induced IED 10 9,762,188 108,776,963 RGD:2302423 RGD
Q Mamtr8 Mammary tumor resistance QTL 8 GBrowse link Induced IED 18 32,458,819 86,863,412 RGD:2302423 RGD
S SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm GBrowse link Induced IED 10 9,762,188 108,776,963 RGD:2302423 RGD
S SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm GBrowse link IED 18 19,892,650 86,863,412 RGD:1643011 RGD
S SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm GBrowse link IED 5 24,978,084 24,978,263 RGD:1643011 RGD
S SS-Chr 12BN/Mcwi Induced IED RGD:4143380 RGD
S SS-Chr 14BN/Mcwi Induced IED RGD:4143380 RGD
S SS-Chr 19BN/Mcwi Induced IED RGD:4143380 RGD
S SS-Chr 3BN/Mcwi Induced IED RGD:4143380 RGD
S SS-Chr 5BN/Mcwi Induced IED RGD:4143380 RGD
S SS-Chr 6BN/Mcwi Induced IED RGD:4143380 RGD
S SS-Chr 9BN/Mcwi Induced IED RGD:4143380 RGD
decreased incidence of induced tumors term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Gcr1 Gastric cancer resistance QTL 1 GBrowse link QTM 4 144,600,129 150,048,167 RGD:69698 RGD
Q Gcr2 Gastric cancer resistance QTL 2 GBrowse link QTM 3 4,010,230 23,762,628 RGD:69698 RGD
Q Gcr3 Gastric cancer resistance QTL 3 GBrowse link QTM 16 18,121,291 70,196,694 RGD:69698 RGD
decreased liver tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Hcar15 Hepatocarcinoma resistance QTL 15 GBrowse link IED 1 156,124,624 247,322,277 RGD:1358145 RGD
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 GBrowse link IED 7 38,076,588 83,076,588 RGD:629574 RGD
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 GBrowse link IED 1 241,199,027 267,910,886 RGD:629574 RGD
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 GBrowse link IED 2 1 41,032,214 RGD:737884 RGD
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 GBrowse link IED 13 1 43,835,207 RGD:737884 RGD
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 GBrowse link IED 13 62,072,299 94,306,205 RGD:737884 RGD
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 GBrowse link IED 13 78,189,125 111,154,910 RGD:737884 RGD
decreased mammary gland tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Emca10 Estrogen-induced mammary cancer QTL 10 GBrowse link IED 6 1,301,952 46,301,952 RGD:2292503 RGD
Q Mamtr1 Mammary tumor resistance QTL 1 GBrowse link IED 5 12,880,403 119,333,229 RGD:631852 RGD
Q Mamtr2 Mammary tumor resistance QTL 2 GBrowse link IED 2 5,601,528 10,539,334 RGD:724790 RGD
Q Mamtr3 Mammary tumor resistance QTL 3 GBrowse link IED 2 32,051,319 43,376,636 RGD:724790 RGD
Q Mamtr4 Mammary tumor resistance QTL 4 GBrowse link IED 2 14,747,814 59,747,814 RGD:724790 RGD
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IED RGD:5684388 RGD
S SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm GBrowse link IED 18 19,892,650 86,863,412 RGD:2302423 RGD
S SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm GBrowse link IED 5 24,978,084 24,978,263 RGD:2302423 RGD
S WF.WKY-(D5Uwm67-D5Uwm98)/Uwm GBrowse link Induced IED 5 79,919,505 79,919,776 RGD:5684388 RGD
S WF.WKY-(D5Uwm76-D5Got18)/Uwm GBrowse link Induced IED 5 82,406,661 82,406,827 RGD:5684388 RGD
S WF.WKY-(D5Uwm76-D5Uwm61)/Uwm GBrowse link Induced IED 5 84,434,303 84,434,576 RGD:5684388 RGD
S WF.WKY-(D5Uwm76-D5Uwm92)/Uwm Induced IED RGD:5684388 RGD
S WF.WKY-(D5Uwm76-D5Uwm98)/Uwm Induced IED RGD:5684388 RGD
S WF.WKY-(D5Uwm77-D5Uwm91)/Uwm IED RGD:5684388 RGD
S WF.WKY-(D5Uwm78-D5Uwm93)/Uwm Induced IED RGD:5684388 RGD
S WF.WKY-(D5Uwm78-D5Uwm98)/Uwm GBrowse link Induced IED 5 82,406,661 82,406,827 RGD:5684388 RGD
S WF.WKY-(D5Uwm82-D5Uwm91)/Uwm IED RGD:5684388 RGD
S WF.WKY-(D5Uwm82-D5Uwm92)/Uwm IED RGD:5684388 RGD
S WF.WKY-(D5Uwm85-D5Uwm92)/Uwm IED RGD:5684388 RGD
S WKY/NHsd IED RGD:1581951 RGD
decreased tongue tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Tcat1 Tongue tumor resistance QTL 1 GBrowse link QTM 1 101,971,983 146,971,983 RGD:61091 RGD
decreased tumor latency term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S SS.BN-(D6Rat119-D6Arb3)/Mcwi GBrowse link Induced IED 6 111,239,053 138,260,635 RGD:4143380 RGD
endometrial carcinoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Edcs1 Endometrial carcinoma susceptibility QTL1 GBrowse link Susceptibility IED 11 19,445,919 24,982,397 RGD:1599856 RGD
Q Edcs2 Endometrial carcinoma susceptibility QTL2 GBrowse link Susceptibility IED 12 7,382,953 27,853,771 RGD:1599856 RGD
Q Edcs3 Endometrial carcinoma susceptibility QTL3 GBrowse link Susceptibility IED 20 1,675,005 2,780,205 RGD:1599856 RGD
Q Edcs4 Endometrial carcinoma susceptibility QTL 4 GBrowse link Susceptibility IED 1 221,868,279 247,322,277 RGD:1599856 RGD
Q Edcs5 Endometrial carcinoma susceptibility QTL 5 GBrowse link Susceptibility IED 17 65,900,398 82,125,463 RGD:1599856 RGD
S BDII/Ztm Susceptibility IED RGD:1599856 RGD
S BDII/Ztm Model TAS RGD:1599853 RGD
gastric adenocarcinoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S ACI.BUF-(D15Rat97-D15Rat29)/Ncc GBrowse link Induced TAS 15 78,048,029 108,387,411 RGD:1302502 RGD
S BUF.ACI-(D15Rat68-D15Rat29)/Ncc GBrowse link Induced TAS 15 62,521,452 108,387,411 RGD:1302502 RGD
S BUF.ACI-(D16Rat31-D16Arb1)/Ncc GBrowse link Induced TAS 16 8,340,080 8,340,453 RGD:1302502 RGD
S BUF.ACI-(D3Rat56-D3Rat83)/Ncc GBrowse link Induced TAS 3 3,577,905 42,635,088 RGD:1302502 RGD
S BUF.ACI-(D4Rat192-D4Rat66)/Ncc GBrowse link Induced TAS 4 161,023,350 161,023,765 RGD:1302502 RGD
S BUF.ACI-(D4Rat226-D4Rat109)/Ncc GBrowse link Induced TAS 4 61,542,056 117,094,107 RGD:1302502 RGD
hepatocellular carcinoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 GBrowse link IED 7 96,649,133 137,404,381 RGD:619598 RGD
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 GBrowse link IED 1 6,253,946 116,153,262 RGD:619598 RGD
S ACI/N A X C 9935, Irish TAS RGD:1004 RGD
S BUF/N TAS RGD:1004 RGD
S DON Donryu rat TAS RGD:1004 RGD
S DRH/Seac Resistance TAS RGD:625382 RGD
S F344/NRrrc TAS RGD:619598 RGD
S LEC TAS RGD:1004 RGD
S WKAH.LEC-Atp7bhts/Tj GBrowse link TAS 16 74,607,988 74,680,080 RGD:1302502 RGD
increased adrenal gland tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S A990 TAS RGD:1004 RGD
S BDII TAS RGD:1004 RGD
S BUF/N TAS RGD:1004 RGD
S DON Donryu rat TAS RGD:1004 RGD
S LEW Lewis TAS RGD:1004 RGD
S M520 TAS RGD:1004 RGD
S M520/N TAS RGD:1004 RGD
S NEDH TAS RGD:1004 RGD
S OM Osborne-Mendel TAS RGD:1004 RGD
S OM/N Osborne-Mendel TAS RGD:1004 RGD
S WAG TAS RGD:1004 RGD
increased classified tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S STOCK-Tp53tm1(EGFP-Pac)QlyRrrc p53 knockout rat Model TAS RGD:2292495 RGD
increased colonic adenoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
G ApcPirc adenomatous polyposis coli IED RGD:1601201 RGD
Q Colcr1 Colorectal carcinoma resistance QTL 1 GBrowse link IED 4 1 26,178,440 RGD:1625309 RGD
Q Colcr2 Colorectal carcinoma resistance QTL 2 GBrowse link IED 15 2,306,220 25,410,881 RGD:1625309 RGD
Q Colcr3 Colorectal carcinoma resistance QTL 3 GBrowse link IED 18 2,571,631 22,807,391 RGD:1625309 RGD
Q Colcr4 Colorectal carcinoma resistance QTL4 GBrowse link IED 6 33,021,033 64,955,579 RGD:1625309 RGD
Q Colcr5 Colorectal carcinoma resistance QTL 5 GBrowse link IED 6 127,683,728 144,152,572 RGD:1625309 RGD
Q Colcr6 Colorectal carcinoma resistance QTL 6 GBrowse link IED 15 80,361,961 107,849,649 RGD:1625309 RGD
Q Colcr7 Colorectal carcinoma resistance QTL 7 GBrowse link IED 17 7,696,509 27,724,805 RGD:1625309 RGD
Q Colcr8 Colorectal carcinoma resistance QTL 8 GBrowse link IED 18 22,807,203 54,605,912 RGD:1625309 RGD
Q Colcr9 Colorectal carcinoma resistance QTL 9 GBrowse link IED 20 1 32,560,683 RGD:1625309 RGD
Q Colcs1 Colorectal carcinoma susceptibility QTL 1 IED RGD:1625309 RGD
S F344-ApcPircUwm IED RGD:1601201 RGD
S WF Wistar Furth TAS RGD:1004 RGD
S WF/CrCrli IED RGD:1625309 RGD
increased hepatoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 GBrowse link IED 1 146,971,846 228,781,113 RGD:629566 RGD
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 GBrowse link IED 16 4,304,396 50,266,190 RGD:629566 RGD
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 GBrowse link IED 1 180,678,929 265,343,617 RGD:737884 RGD
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 GBrowse link IED 14 41,608,939 89,192,873 RGD:737884 RGD
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 GBrowse link IED 15 2,306,220 43,057,384 RGD:737884 RGD
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 GBrowse link IED 16 1 24,132,402 RGD:1599590 RGD
S F344.BN-(D16Mit5-D16Rat75) GBrowse link IED 16 24,131,965 24,132,402 RGD:1599590 RGD
increased incidence of chemically-induced tumors term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S ACI.BUF-(D15Rat97-D15Rat29)/Ncc GBrowse link Induced TAS 15 78,048,029 108,387,411 RGD:1302502 RGD
S BUF.ACI-(D15Rat68-D15Rat29)/Ncc GBrowse link Induced TAS 15 62,521,452 108,387,411 RGD:1302502 RGD
S BUF.ACI-(D16Rat31-D16Arb1)/Ncc GBrowse link Induced TAS 16 8,340,080 8,340,453 RGD:1302502 RGD
S BUF.ACI-(D3Rat56-D3Rat83)/Ncc GBrowse link Induced TAS 3 3,577,905 42,635,088 RGD:1302502 RGD
S BUF.ACI-(D4Rat192-D4Rat66)/Ncc GBrowse link Induced TAS 4 161,023,350 161,023,765 RGD:1302502 RGD
S BUF.ACI-(D4Rat226-D4Rat109)/Ncc GBrowse link Induced TAS 4 61,542,056 117,094,107 RGD:1302502 RGD
S SS-Chr 3BN/Mcwi Induced IED RGD:4143380 RGD
S SS.BN-(D6Rat119-D6Arb3)/Mcwi GBrowse link Induced IED 6 111,239,053 138,260,635 RGD:4143380 RGD
increased incidence of induced tumors term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Gcs1 Gastric cancer susceptibility QTL1 GBrowse link QTM 15 83,349,477 108,387,242 RGD:69698 RGD
Q Schws1 Schwannoma susceptibility QTL 1 GBrowse link IAGP 10 63,816,942 108,816,942 RGD:1559300 RGD
Q Schws2 Schwannoma susceptibility QTL 2 IAGP RGD:1559300 RGD
Q Schws3 Schwannoma susceptibility QTL 3 GBrowse link IAGP 3 120,714,678 165,714,678 RGD:1559300 RGD
Q Schws4 Schwannoma susceptibility QTL 4 GBrowse link IAGP 6 76,340,580 121,340,580 RGD:1559300 RGD
Q Schws5 Schwannoma susceptibility QTL 5 GBrowse link IAGP 13 65,464,406 110,464,406 RGD:1559300 RGD
Q Schws6 Schwannoma susceptibility QTL 6 GBrowse link IAGP 15 60,849,424 105,849,424 RGD:1559300 RGD
Q Schws7 Schwannoma susceptibility QTL 7 GBrowse link IAGP 10 1 41,641,939 RGD:1559300 RGD
S BDIX/Zte IAGP RGD:1559300 RGD
S LUDW TAS RGD:1004 RGD
S M520 TAS RGD:1004 RGD
S M520/N TAS RGD:1004 RGD
increased intestinal adenoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S ACI/N A X C 9935, Irish TAS RGD:1004 RGD
increased lymphoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S ACH TAS RGD:1004 RGD
S WF Wistar Furth TAS RGD:1004 RGD
increased mammary gland tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Mcs29 Mammary carcinoma susceptibility QTL 29 IED RGD:5684388 RGD
S WF.WKY-(D5Uwm67-D5Uwm78)/Uwm GBrowse link Induced IED 5 79,919,505 79,919,776 RGD:5684388 RGD
S WF.WKY-(D5Uwm67-D5Uwm81)/Uwm GBrowse link Induced IED 5 79,919,505 79,919,776 RGD:5684388 RGD
S WF.WKY-(D5Uwm78-D5Uwm84)/Uwm Induced IED RGD:5684388 RGD
S WF.WKY-(D5Uwm87-D5Uwm92)/Uwm Induced IED RGD:5684388 RGD
S WF.WKY-(D5Uwm88-D5Uwm92)/Uwm Induced IED RGD:5684388 RGD
S WF.WKY-(D5Uwm95-D5Uwm98)/Uwm GBrowse link Induced IED 5 82,406,661 82,406,827 RGD:5684388 RGD
increased neurofibrosarcoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S ACI/N A X C 9935, Irish TAS RGD:1004 RGD
increased pituitary adenoma incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S AXC TAS RGD:1004 RGD
S BN BN TAS RGD:1004 RGD
S BUF/N TAS RGD:1004 RGD
S DON Donryu rat TAS RGD:1004 RGD
S LEW Lewis TAS RGD:1004 RGD
S OM Osborne-Mendel TAS RGD:1004 RGD
S OM/N Osborne-Mendel TAS RGD:1004 RGD
S WAG TAS RGD:1004 RGD
S WF Wistar Furth TAS RGD:1004 RGD
S WF/Pit Wistar Furth TAS RGD:1004 RGD
S WN/N Inbred Wistar; W/N TAS RGD:1004 RGD
increased prostate gland tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Prcr1 Prostate cancer resistance QTL 1 GBrowse link IED 2 73,374,972 163,154,358 RGD:1358944 RGD
Q Prcr2 Prostate cancer resistance QTL 2 IED RGD:1358944 RGD
Q Prcs1 Prostate cancer susceptibility QTL 1 GBrowse link IED 19 16,245,310 36,472,155 RGD:1358944 RGD
Q Prcs2 Prostate cancer susceptibility QTL 2 GBrowse link IED 20 4,740,609 18,411,969 RGD:1358944 RGD
increased tongue tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Tcas1 Tongue tumor susceptibility QTL 1 GBrowse link IED 19 4,034,890 49,034,890 RGD:61091 RGD
Q Tcas10 Tongue tumor susceptibility QTL 10 GBrowse link IED 10 33,351,756 78,351,756 RGD:634723 RGD
Q Tcas11 Tongue tumor susceptibility QTL 11 GBrowse link IED 5 17,517,235 168,005,953 RGD:1578522 RGD
Q Tcas2 Tongue tumor susceptibility QTL 2 GBrowse link IED 1 197,423,292 204,280,406 RGD:631169 RGD
Q Tcas3 Tongue tumor susceptibility QTL 3 GBrowse link IED 4 6,179,441 91,330,582 RGD:631169 RGD
Q Tcas4 Tongue tumor susceptibility QTL 4 GBrowse link IED 14 19,141,961 45,020,354 RGD:631169 RGD
Q Tcas5 Tongue tumor susceptibility QTL 5 GBrowse link IED 19 11,456,899 41,612,881 RGD:634723 RGD
Q Tcas6 Tongue tumor susceptibility QTL 6 GBrowse link IED 1 92,101,613 146,971,983 RGD:634723 RGD
Q Tcas7 Tongue tumor susceptibility QTL 7 GBrowse link IED 19 26,536,747 41,612,881 RGD:1358147 RGD
Q Tcas8 Tongue tumor susceptibility QTL 8 IED RGD:634723 RGD
Q Tcas9 Tongue tumor susceptibility QTL 9 GBrowse link IED 6 1 25,291,384 RGD:634723 RGD
increased tumor incidence term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
G Xrcc6 X-ray repair complementing defective repair in Chinese hamster cells 6 GBrowse link IEA 7 120,401,944 120,422,923 RGD:704404 RGD
Q Mcs21 Mammary carcinoma susceptibility QTL 21 GBrowse link Induced TAS 10 29,541,648 54,220,239 RGD:2302423 RGD
Q Mcs22 Mammary carcinoma susceptibility QTL 22 GBrowse link Induced TAS 18 54,856,551 67,024,547 RGD:2302423 RGD
S DON Donryu rat TAS RGD:1004 RGD
S F344-ApcPircUwm IED RGD:1601201 RGD
S HMT IED RGD:724737 RGD
S LOU IED RGD:634815 RGD
S LOU/CHan Louvain TAS RGD:1004 RGD
S M520 TAS RGD:1004 RGD
S M520/N TAS RGD:1004 RGD
S OM Osborne-Mendel TAS RGD:1004 RGD
S OM/N Osborne-Mendel TAS RGD:1004 RGD
intestinal adenocarcinoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S F344-ApcPircUwm IED RGD:1601201 RGD
leukemia term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S LE/Stm IED RGD:619600 RGD
S LEXF QTM RGD:619600 RGD
S LEXF10A/Stm QTM RGD:619600 RGD
S LEXF10B/Stm QTM RGD:619600 RGD
S LEXF10C/Stm QTM RGD:619600 RGD
S LEXF11/Stm QTM RGD:619600 RGD
S LEXF1A/Stm QTM RGD:619600 RGD
S LEXF1C/Stm QTM RGD:619600 RGD
S LEXF2A/Stm QTM RGD:619600 RGD
S LEXF2B/Stm QTM RGD:619600 RGD
S LEXF3/Stm QTM RGD:619600 RGD
S LEXF4/Stm QTM RGD:619600 RGD
S LEXF5/Stm QTM RGD:619600 RGD
S LEXF6B/Stm QTM RGD:619600 RGD
S LEXF7A/Stm QTM RGD:619600 RGD
S LEXF7B/Stm QTM RGD:619600 RGD
S LEXF7C/Stm QTM RGD:619600 RGD
S LEXF8A/Stm QTM RGD:619600 RGD
S LEXF9/Stm QTM RGD:619600 RGD
S WF Wistar Furth TAS RGD:1004 RGD
S WF/CrCrli IED RGD:1625309 RGD
malignant tumors term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S BDII/Ztm Onset TAS RGD:1599853 RGD
S BDIX TAS RGD:1004 RGD
mammary adenocarcinoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Emca1 Estrogen-induced mammary cancer QTL 1 GBrowse link IAGP 5 103,677,659 155,120,876 RGD:1358124 RGD
Q Emca2 Estrogen-induced mammary cancer QTL 2 GBrowse link IAGP 18 18,562,790 66,652,461 RGD:1358124 RGD
Q Emca4 Estrogen-induced mammary cancer QTL 4 GBrowse link Susceptibility IED 7 66,201,980 107,428,439 RGD:1642522 RGD
Q Emca5 Estrogen-induced mammary cancer QTL 5 GBrowse link Susceptibility IED 3 41,054,012 171,063,335 RGD:1642522 RGD
Q Emca6 Estrogen-induced mammary cancer QTL 6 GBrowse link Susceptibility IED 4 41,729,583 159,115,617 RGD:1642522 RGD
Q Emca7 Estrogen-induced mammary cancer QTL 7 GBrowse link IED 6 2,802,670 111,967,837 RGD:1642522 RGD
Q Emca8 Estrogen-induced mammary cancer QTL 8 GBrowse link Susceptibility IED 5 52,434,178 148,460,381 RGD:1642522 RGD
Q Mamtr5 Mammary tumor resistance QTL 5 GBrowse link IED 5 19,206,257 64,206,257 RGD:1599390 RGD
Q Mamtr6 Mammary tumor resistance QTL 6 GBrowse link IED 18 19,892,650 86,863,412 RGD:1599390 RGD
Q Mamtr7 Mammary tumor resistance QTL 7 GBrowse link Induced IED 10 9,762,188 108,776,963 RGD:2302423 RGD
Q Mamtr8 Mammary tumor resistance QTL 8 GBrowse link Induced IED 18 32,458,819 86,863,412 RGD:2302423 RGD
Q Mcs1 Mammary carcinoma susceptibility QTL 1 GBrowse link QTM 2 5,601,528 22,318,848 RGD:61080 RGD
Q Mcs15 Mammary carcinoma susceptibility QTL 15 GBrowse link IED 10 89,575,059 108,822,775 RGD:1581951 RGD
Q Mcs16 Mammary carcinoma susceptibility QTL 16 GBrowse link IED 1 2,436,832 37,799,020 RGD:1599317 RGD
Q Mcs17 Mammary carcinoma susceptibility QTL 17 GBrowse link IED 1 202,763,018 247,763,018 RGD:1599317 RGD
Q Mcs18 Mammary carcinoma susceptibility QTL 18 GBrowse link IED 2 5,601,528 35,247,994 RGD:1599317 RGD
Q Mcs19 Mammary carcinoma susceptibility QTL 19 GBrowse link IED 5 103,956,411 108,590,465 RGD:1599317 RGD
Q Mcs2 Mammary carcinoma susceptibility QTL 2 GBrowse link QTM 7 21,161,002 38,377,911 RGD:61081 RGD
Q Mcs20 Mammary carcinoma susceptibility QTL 20 GBrowse link IED 9 8,991,206 39,691,794 RGD:1599317 RGD
Q Mcs21 Mammary carcinoma susceptibility QTL 21 GBrowse link IED 10 29,541,648 54,220,239 RGD:1599317 RGD
Q Mcs22 Mammary carcinoma susceptibility QTL 22 GBrowse link IED 18 54,856,551 67,024,547 RGD:1599317 RGD
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IED RGD:1601189 RGD
Q Mcs24 Mammary carcinoma susceptibility QTL 24 GBrowse link IED 5 70,181,758 115,181,758 RGD:1601189 RGD
Q Mcs25 Mammary carcinoma susceptibility QTL 25 GBrowse link Induced IED 6 7,161,389 115,238,799 RGD:4143380 RGD
Q Mcs26 Mammary carcinoma susceptibility QTL 26 GBrowse link Induced IED 6 111,239,053 138,260,635 RGD:4143380 RGD
Q Mcs27 Mammary carcinoma susceptibility QTL 27 GBrowse link Induced IED 13 44,872,181 49,428,577 RGD:4143380 RGD
Q Mcs3 Mammary carcinoma susceptibility QTL 3 GBrowse link QTM 1 102,532,145 134,980,682 RGD:61081 RGD
Q Mcs4 Mammary carcinoma susceptibility QTL 4 GBrowse link QTM 8 61,443,447 64,762,616 RGD:61081 RGD
Q Mcs5 Mammary carcinoma susceptibility QTL 5 GBrowse link QTM 5 58,063,971 139,156,771 RGD:62417 RGD
Q Mcs6 Mammary carcinoma susceptibility QTL 6 GBrowse link QTM 7 29,204,226 68,057,251 RGD:62417 RGD
Q Mcs7 Mammary carcinoma susceptibility QTL 7 GBrowse link QTM 10 76,698,917 121,698,917 RGD:62417 RGD
Q Mcs8 Mammary carcinoma susceptibility QTL 8 GBrowse link QTM 14 4,895,894 26,416,791 RGD:62417 RGD
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 GBrowse link QTM 6 61,787,263 106,787,263 RGD:62417 RGD
S A7322 TAS RGD:1004 RGD
S A990 TAS RGD:1004 RGD
S ACI.COP-(D10Mgh8-D10Rat4)/Shul GBrowse link Induced IED 10 53,781,126 107,033,716 RGD:2292503 RGD
S ACI.COP-(D3Mgh16-D3Rat119)/Shul GBrowse link Induced IED 3 6,373,335 52,643,538 RGD:2292503 RGD
S ACI.COP-(D3Rat130-D3Rat114)/Shul GBrowse link Induced IED 3 44,551,252 149,496,698 RGD:2292503 RGD
S ACI.COP-(D6Rat80-D6Rat146)/Shul GBrowse link Induced IED 6 16,302,145 16,302,283 RGD:2292503 RGD
S ACI/N A X C 9935, Irish TAS RGD:1004 RGD
S ACI/SegHsd Model IED RGD:1358124 RGD
S ACI/SegHsd IED RGD:1358963 RGD
S ACI/SegHsd Susceptibility IED RGD:1642522 RGD
S AXC TAS RGD:1004 RGD
S BN/NHsdMcwi Resistance IED RGD:2301186 RGD
S BN/SsNHsd Resistance IED RGD:1642522 RGD
S BUF/N TAS RGD:1004 RGD
S DON Donryu rat TAS RGD:1004 RGD
S LEW Lewis TAS RGD:1004 RGD
S NSD/N TAS RGD:1004 RGD
S OM/N Osborne-Mendel TAS RGD:1004 RGD
S SD-Tg(MMTV-Esrrb)1UwmRrrc Model IED RGD:6482679 RGD
S SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm GBrowse link Induced IED 10 9,762,188 108,776,963 RGD:2302423 RGD
S SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm GBrowse link IED 18 19,892,650 86,863,412 RGD:1599390 RGD
S SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm GBrowse link IED 5 24,978,084 24,978,263 RGD:1599390 RGD
S SPRD/Hsd Susceptibility TAS RGD:2291885 RGD
S SPRD/Ztm IED RGD:1599317 RGD
S SS-Chr 10BN/Mcwi Susceptibility IED RGD:2301186 RGD
S SS-Chr 12BN/Mcwi Susceptibility IED RGD:2301186 RGD
S SS.BN-(D13Rat111-D13Got22)/Mcwi GBrowse link Induced IED 13 32,030,139 42,627,837 RGD:4143380 RGD
S SS.BN-(D13Rat123-D13Rat101)/Mcwi GBrowse link Induced IED 13 44,872,181 49,428,577 RGD:4143380 RGD
S SS.BN-(D13Rat151-D13Rat197)/Mcwi GBrowse link Induced IED 13 80,109,432 100,133,413 RGD:4143380 RGD
S SS.BN-(D13Rat7-D13Rat60)/Mcwi GBrowse link Induced IED 13 1,084,268 13,053,933 RGD:4143380 RGD
S SS.BN-(D6Rat119-D6Arb3)/Mcwi GBrowse link Induced IED 6 111,239,053 138,260,635 RGD:4143380 RGD
S SS.BN-(D6Rat149-D6Arb3)/Mcwi GBrowse link Induced IED 6 7,161,389 138,260,635 RGD:4143380 RGD
S SS.BN-(D6Rat149-D6Got171)/Mcwi GBrowse link Induced IED 6 7,161,389 123,782,965 RGD:4143380 RGD
S SS.BN-(D6Rat149-D6Rat18)/Mcwi GBrowse link Induced IED 6 7,161,389 93,374,504 RGD:4143380 RGD
S SS/JrHsdMcwi Susceptibility IED RGD:2301186 RGD
S WF Wistar Furth TAS RGD:1004 RGD
S WF Wistar Furth QTM RGD:61081 RGD
S WF.COP-(D7Rat39-D7Uwm12)/1Uwm GBrowse link IED 7 4,936,703 86,007,499 RGD:5133689 RGD
S WF.COP-(D7Rat39-D7Uwm12)/2Uwm GBrowse link IED 7 4,936,703 86,007,499 RGD:5133689 RGD
S WF.WKY-(D10Got124-D10Rat187)/Uwm GBrowse link IED 10 89,575,059 110,385,665 RGD:1581951 RGD
S WF.WKY-(D7Rat171-D7Rat128)/1Uwm GBrowse link Resistance IED 7 22,382,724 121,524,220 RGD:5133689 RGD
S WF.WKY-(D7Rat171-D7Rat128)/2Uwm GBrowse link Resistance IED 7 22,382,724 121,524,220 RGD:5133689 RGD
S WF.WKY-(D7Rat171-D7Rat45)/Uwm GBrowse link IED 7 22,382,724 68,057,251 RGD:5133689 RGD
S WF.WKY-(D7Rat51-D7Rat128)/Uwm GBrowse link Resistance IED 7 50,833,677 121,524,220 RGD:5133689 RGD
S WF.WKY-(D7Uwm25-D7Rat128)/Uwm GBrowse link IED 7 121,523,977 121,524,220 RGD:5133689 RGD
S WF/NHsd TAS RGD:1581951 RGD
S WF/NHsd Susceptibility TAS RGD:2291885 RGD
S WF/Pit Wistar Furth TAS RGD:1004 RGD
pheochromocytoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
S NEDH TAS RGD:1004 RGD
S WN/N Inbred Wistar; W/N TAS RGD:1004 RGD
T cell derived lymphoma term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Tls1 T-lymphoma susceptibility QTL 1 GBrowse link QTM 5 94,515,803 139,515,803 RGD:619600 RGD
Q Tls2 T-lymphoma susceptibility QTL 2 GBrowse link QTM 7 85,090,032 137,838,850 RGD:619600 RGD
Q Tls3 T-lymphoma susceptibility QTL 3 GBrowse link QTM 10 53,781,298 100,090,301 RGD:619600 RGD
S LEXF QTM RGD:619600 RGD
S LEXF10A/Stm QTM RGD:619600 RGD
S LEXF10B/Stm QTM RGD:619600 RGD
S LEXF10C/Stm QTM RGD:619600 RGD
S LEXF11/Stm QTM RGD:619600 RGD
S LEXF1A/Stm QTM RGD:619600 RGD
S LEXF1C/Stm QTM RGD:619600 RGD
S LEXF2A/Stm QTM RGD:619600 RGD
S LEXF2B/Stm QTM RGD:619600 RGD
S LEXF3/Stm QTM RGD:619600 RGD
S LEXF4/Stm QTM RGD:619600 RGD
S LEXF5/Stm QTM RGD:619600 RGD
S LEXF6B/Stm QTM RGD:619600 RGD
S LEXF7A/Stm QTM RGD:619600 RGD
S LEXF7B/Stm QTM RGD:619600 RGD
S LEXF7C/Stm QTM RGD:619600 RGD
testis tumor term browser
Symbol Object Name GBrowse Qualifiers Evidence Chr Start Stop Reference Source
Q Tescar1 Testicular tumor resistance QTL 1 GBrowse link IAGP 11 597,138 67,931,151 RGD:1358944 RGD
Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 6279
    tumorigenesis 322
      altered tumor susceptibility 316
        abnormal tumor incidence + 315
        abnormal tumor latency + 1
        preneoplasia 0
paths to the root

Contact Us |  About Us |  Jobs at RGD